HydroMID® and HydroPICC®:

The Future of Vascular Access Is Here

Learn More
Learn More

Its time to put an end to polyurethane catheters and move treatment forward with a solution, specifically designed to address the most common and costly complications in vascular access today. HydroPICC® and HydroMID® with MIMIX® Technology, are the only drug-free catheters with an anti-thrombogenic indication from the FDA.*

Thrombus? Not Us.

  • Fewer complications:

    Our hydrophilic catheters have demonstrated reduced thrombosis, occlusions, and other complications compared to polyurethane catheters¹ ²

  • A better patient experience:

    Fewer occlusions and replacements mean fewer unnecessary sticks for patients

  • Improved workflows for nurses:

    Hydrophilic catheters work with nurses, not against them, for easier vascular access

DISCOVER THE DIFFERENCE

MIMIX® Technology:

Setting the New Standard for Performance

Attending AVA 2026? Stop By and See Us!

Booth 310 | October 2–4 | Grapevine, TX

The Access Vascular team will be on hand to  share the benefits of our innovative HydroMID® and HydroPICC® catheters along with our new partnership with Medline. You’ll also get a sneak peek at our new findings in our latest research posters.

Lock In Your Walkthrough

Secure your chance to see firsthand how HydroMID® and HydroPICC® are moving vascular access forward.

*FDA 510(k) K243458: includes HydroPICC single-lumen and dual-lumen, and HydroMID single-lumen.

Sources: 

  1. A Retrospective Assessment of Peripheral Catheter Failures Focusing on Catheter Composition. Journal of Infusion Nursing. 45(5):p 270-278, September/October 2022.

  2. A retrospective, comparative, clinical study of occlusion rate of peripherally inserted central catheters fabricated of poly(vinyl alcohol)-based hydrogel composite. Journal of Materials Science: Materials Science in Medicine (2023) 34:34.

  3. Presented at the Infusion Nurses Society Annual Meeting; 2025. Data on file: ML-0499

  4. J Mater Sci Mater Med. 2023 Jul 21;34(7):34. doi: 10.1007/s10856-023-06736-0. Study conducted using the HydroPICC® Single Lumen Catheter.